Immunyx Pharma vs Upstream Bio

Immunyx Pharma vs Upstream Bio, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunyx Pharma is on 46/100 and Upstream Bio on 61/100.

Immunyx Pharma logo
Immunyx PharmaBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
Try Immunyx Pharma
Upstream Bio logo
Upstream BioClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Try Upstream Bio

Where each one leads

Immunyx Pharma

Leads on none of the measures we hold for both companies.

Upstream Bio

  • our overall score: 61/100 against 46/100
  • domain rating: 32/100 against 6/100
  • headcount: 75 against 6
  • headcount growth: +43.4% against +6.0%
  • LinkedIn following: 11,799 against 858

At a glance

MeasureImmunyx PharmaUpstream Bio
What it isBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
CategoryLife Sciences, Biopharmaceutical, Drug Development, BiotechLife Sciences, Therapeutics, Biotech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20172021
HeadquartersNew York, United StatesWaltham, United States
StatusActiveActive

Size, funding and growth

MeasureImmunyx PharmaUpstream Bio
Employees675
Headcount growthLast 12 months+6.0%+43.4%
Total fundingNot published$400M
Latest roundNot publishedSeries B
LinkedIn followers85811,799

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunyx PharmaUpstream Bio
StartupHub scoreOur 0-100 rating46/10061/100
Traction8/10059/100
Team60/10070/100
Search visibility32/10037/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteD (41/100)F (39/100)
Domain ratingLink authority, 0-1006/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunyx PharmaUpstream Bio
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJquery, BootstrapJquery, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

Immunyx Pharma vs Upstream Bio: common questions

Which is better, Immunyx Pharma or Upstream Bio?

On our 0-100 score Upstream Bio rates higher (61/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Immunyx Pharma and Upstream Bio compare on the numbers?

Upstream Bio leads on our overall score (61/100 against 46/100), domain rating (32/100 against 6/100), headcount (75 against 6), headcount growth (+43.4% against +6.0%), LinkedIn following (11,799 against 858).

Read the full Immunyx Pharma review and pricing or the Upstream Bio review and pricing. You can also browse other Immunyx Pharma alternatives we track.